Delivery Order SPE2DB20D3111-SPE2DB25FA9CV
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $8,727.91 to AmerisourceBergen Drug Corp for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, scheduled for completion by August 6, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. BIKTARVY is an antiretroviral medication used in HIV treatment,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,904.16 to AmerisourceBergen Drug Corp for the supply of BIKTARVY 50-200-25 mg tablets in units of 30 on November 14, 2025. This non-competitive, firm fixed-price delivery order is scheduled for completion by November 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. BIKTARVY is a prescription antiretroviral medication used in the treatment of HIV, reflecting the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) with a ceiling value of $15,771.58 under a firm fixed-price contract type. The award was issued on June 30, 2025, with an ultimate completion date of July 1, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location....
- The Defense Logistics Agency awarded a delivery order valued at $74,948.97 to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) on October 28, 2025, with an ultimate completion date of October 29, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. BIKTARVY is an antiretroviral medication used in HIV treatment,...
- The Defense Logistics Agency awarded a $79,157.52 delivery order to AmerisourceBergen Drug Corp for the supply of BIKTARVY 50-200-25 mg tablets (30-count units) under a firm fixed-price contract. This non-set-aside delivery order was competitively awarded on December 2, 2025, with an ultimate completion date of December 3, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. BIKTARVY is an antiretroviral medication used in HIV treatment,...
- The Defense Logistics Agency awarded a delivery order valued at $11,856.23 to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) on May 27, 2025, with an ultimate completion date of May 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. BIKTARVY is an HIV treatment medication, reflecting the federal government's ongoing pharmaceutical...
- The Defense Logistics Agency awarded a $27,168.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) with an ultimate completion date of September 22, 2025. This non-set-aside competitive award was issued on September 19, 2025, with performance occurring at the contractor's corporate office location in Conshohocken, Pennsylvania. BIKTARVY is a prescription antiretroviral medication used in the treatment of HIV, reflecting the broad...
- The Defense Logistics Agency awarded a $15,682.02 delivery order to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 tablets (30-count supply) under a firm fixed-price contract, with performance to be completed by January 29, 2026. BIKTARVY is an antiretroviral medication used in HIV treatment, reflecting the agency's ongoing pharmaceutical procurement needs for military and federal healthcare systems. This non-set-aside award was competitively awarded and represents a child delivery order...
- The Defense Logistics Agency awarded a $15,696.60 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed price, non-set-aside contract with a completion date of July 30, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. BIKTARVY is an antiretroviral medication used in the treatment of HIV infection, reflecting the Defense Logistics Agency's ongoing...
- The Defense Logistics Agency awarded a $46,661.17 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of BIKTARVY 50-200-25 mg tablets (30-count units). This competitive award was issued on October 30, 2025, with an ultimate completion date of October 31, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. BIKTARVY is an antiretroviral medication used in the treatment of HIV infection, representing a critical pharmaceutical...
- SPE2DB20D3111Indefinite Delivery Contract
- SPE2DB20D3111-SPE2DB25FA9CVDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $14,172.87 to AmerisourceBergen Drug Corp for the supply of BIKTARVY 30-120-15 mg tablets (30-count bottles), with an ultimate completion date of August 28, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designations and will be performed at the contractor's facility in Conshohocken, Pennsylvania. BIKTARVY is an antiretroviral medication used in HIV treatment, supporting the federal government's pharmaceutical supply requirements for military and veteran healthcare systems. This award represents a delivery order issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp maintains an extensive portfolio of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply medical commodities to support military healthcare programs and other government healthcare systems worldwide through flexible delivery order arrangements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.2k | 8/27/25 |